Sign in

CIK 0001894562 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Prime Medicine, Inc.

Sign in to watch
Ticker
PRME
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-465-0013
Business address
60 FIRST ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Gift See Remarks gave 250,000 shares (gift)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 3,200,000 shares at $6.25 ($20,000,000)
  17. 4 Open-market buy 10% owner bought 3,200,000 shares at $6.25 ($20,000,000)
  18. 4 Open-market buy 10% owner bought 3,200,000 shares at $6.25 ($20,000,000)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 4 of 7 · 140 filings